SPOTLIGHT: Pfizer snaps up Coley Pharma


Pfizer plans to buy Coley Pharmaceuticals in a $164 million tender offer, hoping to reap new products from Coley's pipeline of vaccine and immunotherapy candidates. Report

Suggested Articles

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

After Merck and Bayer's vericiguat scored in a heart failure trial, you'd expect potential rivals to brace themselves. Not so for Novartis'…